Farside CV relabelling [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2010-11-09 11:42 (5345 d 03:19 ago) – Posting: # 6118
Views: 14,160

Dear Helmut,

❝ Well, I have no idea what Pharsight calculated here ...


Me too. Their formula given on the slide
  +1.25(sigmaRef/0.25)
is clearly nonsense. It would give negative lower bounds!
The correct one is
  exp(+log(1.25)*sigmaRef/0.25)
I think.

Taking the numbers for the widened acceptance ranges given, they seems to have a label problem.
(In German: Wo 35% draufsteht sollte auch 35% drin sein!)
Label their CV=35% with 30%, their CV=40% with 35% and so on and you have perfect coincidence with your values within rounding error :cool:.
Eventually one should remind the author of the slides that labelling falls under the policy of GMP :-D.

Full ACK to all other of your points.

BTW:
<nitpicking> ------------------
I get for the FDA's widened limits:

  CV
 30%  76.95 - 129.96
 35%  73.83 - 135.45
 40%  70.90 - 141.04
 45%  68.16 - 146.71
 50%  65.60 - 152.45
 55%  63.20 - 158.23
 60%  60.96 - 164.04

using R-2.12.0 64bit on my new Intel Core i3 machine with Windows 7 Prof.
</nitpicking> ------------------ :wink:

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,687 registered users;
69 visitors (0 registered, 69 guests [including 5 identified bots]).
Forum time: 16:02 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5